Amneal Pharmaceuticals News, Amneal Pharmaceuticals Quote, AMRX Quote

Amneal Pharmaceuticals (CBOE:AMRX) Delayed: 5448.90 +2.20 (0.04%)

Prev. Close

$5446.70

Open

$5448.90

52 Wk High

$0.19

52 Wk Low

$0.07

Day High

$5448.90

Day Low

$5448.90

P/E

N/A

EPS

$-0.01

Volume

104,135

Friends, Peers and Foes (?): GUD (more...)

Apr 24, 2024 08:00 AM Amneal Pharmaceuticals (AMRX) Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Apr 24, 2024 08:00 AM Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Apr 24, 2024 06:05 AM Form SC 13G/A Amneal Pharmaceuticals, Filed by: Fosun International Ltd
Apr 16, 2024 08:04 AM Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Apr 10, 2024 08:00 AM Amneal to Report First Quarter 2024 Results on May 3, 2024
Mar 28, 2024 04:05 PM Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
Mar 25, 2024 04:06 PM Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Ciprofloxacin and Dexamethasone Otic Suspension
Mar 25, 2024 04:05 PM Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Mar 22, 2024 08:02 AM Form DEFA14A Amneal Pharmaceuticals,
Mar 22, 2024 08:02 AM Form DEF 14A Amneal Pharmaceuticals, For: May 02

Entities mentioned with AMRX